PubRank

M Verstreken

Author PubWeight™ 23.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet 1998 2.52
2 Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988 1.68
3 Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet 1998 1.63
4 Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet 1999 1.54
5 High prevalence of symptoms of Menière's disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999 1.25
6 Hearing impairment and neurological dysfunction associated with a mutation in the mitochondrial tRNASer(UCN) gene. Eur J Hum Genet 1999 1.05
7 An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system. Thromb Haemost 1986 1.00
8 A new autosomal-dominant locus (DFNA12) is responsible for a nonsyndromic, midfrequency, prelingual and nonprogressive sensorineural hearing loss. Am J Otol 1998 0.97
9 Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation. Arterioscler Thromb Vasc Biol 1999 0.94
10 A gene for autosomal dominant nonsyndromic hearing loss (DFNA12) maps to chromosome 11q22-24. Am J Hum Genet 1997 0.94
11 Recombinant staphylokinase variants with altered immunoreactivity. I: Construction and characterization. Circulation 1996 0.93
12 A common ancestor for COCH related cochleovestibular (DFNA9) patients in Belgium and The Netherlands bearing the P51S mutation. J Med Genet 2001 0.92
13 Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 1995 0.89
14 Otosclerosis: a genetically heterogeneous disease involving at least three different genes. Bone 2002 0.86
15 Depletion of circulating alpha(2)-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization. Blood 2001 0.85
16 Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea. Eur J Hum Genet 1998 0.84
17 Generation of monoclonal antibodies against autologous proteins in gene-inactivated mice. J Biol Chem 1995 0.84
18 Transient depression of inner ear function after stapedotomy: skeeter versus CO(2) laser technique. Adv Otorhinolaryngol 2007 0.83
19 Refined localization and two additional linked families for the DFNA10 locus for nonsyndromic hearing impairment. Hum Genet 2000 0.80
20 Involvement of T-cell receptor-beta alterations in the development of otosclerosis linked to OTSC2. Genes Immun 2010 0.79
21 A gene for autosomal dominant hearing impairment (DFNA14) maps to a region on chromosome 4p16.3 that does not overlap the DFNA6 locus. J Med Genet 1999 0.79
22 An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA. Thromb Haemost 1992 0.76
23 Screening panels of monoclonal antibodies using phage-displayed antigen. Anal Biochem 1997 0.75
24 A monoclonal antibody specific for two-chain urokinase-type plasminogen activator. Application to the study of the mechanism of clot lysis with single-chain urokinase-type plasminogen activator in plasma. Blood 1990 0.75
25 Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasma. Thromb Haemost 1991 0.75
26 Enhancement of the otic capsule in active retrofenestral otosclerosis. Otol Neurotol 2004 0.75